Bio-Techne Down Over 10%, on Pace for Largest Percent Decrease Since February 2009 -- Data Talk

Dow Jones04-24 00:05

Bio-Techne Corporation (TECH) is currently at $52.36, down $6.22 or 10.62%

 

--Would be lowest close since March 31, 2026, when it closed at $52.26

--On pace for largest percent decrease since Feb. 3, 2009, when it fell 13.13%

--Currently down three consecutive days; down 13.57% over this period

--Worst three day stretch since the three days ending Jan. 5, 2022, when it fell 15.97%

--Up 0.19% month-to-date; on pace for best month since Jan. 2026, when it rose 8.98%

--Down 10.97% year-to-date

--Down 61.13% from its all-time closing high of $134.72 on Sept. 24, 2021

--Up 3.11% from 52 weeks ago (April 24, 2025), when it closed at $50.78

--Down 26.64% from its 52-week closing high of $71.38 on Jan. 21, 2026

--Up 12.22% from its 52-week closing low of $46.66 on May 21, 2025

--Traded as low as $52.00; lowest intraday level since April 6, 2026, when it hit $51.95

--Down 11.23% at today's intraday low; largest intraday percent decrease since Nov. 5, 2025, when it fell as much as 11.29%

--Third worst performer in the S&P 500 today

 

All data as of 12:03:24 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

April 23, 2026 12:05 ET (16:05 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment